Business Context and Reporting Period
This Form 8-K Current Report was filed by Revelation Biosciences, Inc. on September 27, 2023, with the report date signed on October 2, 2023. The filing discloses changes to the Company's Board of Directors.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on corporate governance changes.
Material Changes
- Resignation of Director: On September 27, 2023, Curt LaBelle, M.D., resigned from the Board of Directors. The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Appointment of Director: On September 27, 2023, the Board elected Lakhmir Chawla, M.D., as a Class C Director to fill the vacancy. Dr. Chawla is an independent director and will serve on the Compensation and Nominations and Corporate Governance Committees.
- Background of New Director: Dr. Chawla is currently the CEO of Stavro Medical. Previously, he served as Chief Medical Officer at Silver Creek Pharma and La Jolla Pharmaceutical Company, where he oversaw Phase 3 clinical trials.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. It notes that Dr. Chawla will receive compensation consistent with other non-employee directors and will enter into a standard indemnification agreement. No actual or proposed transactions requiring disclosure under Item 404(a) of Regulation S-K were identified.
Investor Verification Checklist
- Verify the independence status of the newly appointed director, Dr. Lakhmir Chawla, as defined by NASDAQ listing standards.
- Review the press release (Exhibit 99.1) for additional details on the Board composition and strategic implications.
- Confirm that the resignation of Dr. LaBelle did not signal undisclosed operational issues, as stated in the filing.
- Check subsequent filings for the execution of the standard indemnification agreement and offer letter for Dr. Chawla.